Moses M. Kasembeli

1.7k total citations
25 papers, 1.3k citations indexed

About

Moses M. Kasembeli is a scholar working on Oncology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Moses M. Kasembeli has authored 25 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 11 papers in Molecular Biology and 6 papers in Infectious Diseases. Recurrent topics in Moses M. Kasembeli's work include Cytokine Signaling Pathways and Interactions (16 papers), Heat shock proteins research (5 papers) and Tuberculosis Research and Epidemiology (4 papers). Moses M. Kasembeli is often cited by papers focused on Cytokine Signaling Pathways and Interactions (16 papers), Heat shock proteins research (5 papers) and Tuberculosis Research and Epidemiology (4 papers). Moses M. Kasembeli collaborates with scholars based in United States and China. Moses M. Kasembeli's co-authors include David J. Tweardy, Uddalak Bharadwaj, Prema Robinson, T. Kris Eckols, Soung‐Hun Roh, Wah Chiu, Mikhail Kolosov, Xuejun Xu, Xueqing Jiang and Wilson Chun Yu Lau and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Blood.

In The Last Decade

Moses M. Kasembeli

25 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Moses M. Kasembeli United States	17	659	498	223	191	127	25	1.3k
Ken Ohmine Japan	21	605 0.9×	528 1.1×	119 0.5×	110 0.6×	124 1.0×	82	1.4k
Abhisek Swaika United States	15	475 0.7×	549 1.1×	175 0.8×	155 0.8×	145 1.1×	30	1.1k
Fujun Li China	20	607 0.9×	345 0.7×	186 0.8×	69 0.4×	202 1.6×	62	1.3k
Ran Zhao United States	25	1.2k 1.8×	520 1.0×	140 0.6×	156 0.8×	367 2.9×	72	1.7k
Anne‐Marie Faussat France	26	1.1k 1.6×	648 1.3×	164 0.7×	120 0.6×	242 1.9×	46	1.9k
Tsunekazu Kita Japan	24	876 1.3×	433 0.9×	137 0.6×	163 0.9×	222 1.7×	89	1.8k
Debra A. Tonetti United States	26	935 1.4×	662 1.3×	178 0.8×	111 0.6×	245 1.9×	57	1.7k
Wolfram C. M. Dempke Germany	20	727 1.1×	727 1.5×	283 1.3×	136 0.7×	258 2.0×	48	1.8k
Ashwini L. Chand Australia	22	753 1.1×	566 1.1×	329 1.5×	128 0.7×	242 1.9×	41	1.6k
Hudie Wei China	14	835 1.3×	550 1.1×	211 0.9×	93 0.5×	220 1.7×	31	1.5k

Countries citing papers authored by Moses M. Kasembeli

Since Specialization

Citations

This map shows the geographic impact of Moses M. Kasembeli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moses M. Kasembeli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moses M. Kasembeli more than expected).

Fields of papers citing papers by Moses M. Kasembeli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moses M. Kasembeli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moses M. Kasembeli. The network helps show where Moses M. Kasembeli may publish in the future.

Co-authorship network of co-authors of Moses M. Kasembeli

This figure shows the co-authorship network connecting the top 25 collaborators of Moses M. Kasembeli. A scholar is included among the top collaborators of Moses M. Kasembeli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moses M. Kasembeli. Moses M. Kasembeli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wurster, Sebastian, Nathaniel D. Albert, Uddalak Bharadwaj, et al.. (2022). Blockade of the PD-1/PD-L1 Immune Checkpoint Pathway Improves Infection Outcomes and Enhances Fungicidal Host Defense in a Murine Model of Invasive Pulmonary Mucormycosis. Frontiers in Immunology. 13. 838344–838344. 28 indexed citations

Kasembeli, Moses M., Pooja Singhmar, Jiacheng Ma, et al.. (2021). TTI-101: A competitive inhibitor of STAT3 that spares oxidative phosphorylation and reverses mechanical allodynia in mouse models of neuropathic pain. Biochemical Pharmacology. 192. 114688–114688. 30 indexed citations

Kong, Ren, Uddalak Bharadwaj, T. Kris Eckols, et al.. (2021). Novel STAT3 small-molecule inhibitors identified by structure-based virtual ligand screening incorporating SH2 domain flexibility. Pharmacological Research. 169. 105637–105637. 14 indexed citations

Bharadwaj, Uddalak, Moses M. Kasembeli, Prema Robinson, & David J. Tweardy. (2020). Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution. Pharmacological Reviews. 72(2). 486–526. 230 indexed citations

Wang, Haopei, Alexandra M. Stevens, Michael Krueger, et al.. (2020). Targeting STAT3 anti-apoptosis pathways with organic and hybrid organic–inorganic inhibitors. Organic & Biomolecular Chemistry. 18(17). 3288–3296. 11 indexed citations

Zhang, Ping, Ying Wang, Yanlan Dong, et al.. (2020). Pharmacokinetics and pharmacodynamics of TTI-101, a STAT3 inhibitor that blocks muscle proteolysis in rats with chronic kidney disease. American Journal of Physiology-Renal Physiology. 319(1). F84–F92. 20 indexed citations

Kasembeli, Moses M., Uddalak Bharadwaj, Prema Robinson, & David J. Tweardy. (2018). Contribution of STAT3 to Inflammatory and Fibrotic Diseases and Prospects for its Targeting for Treatment. International Journal of Molecular Sciences. 19(8). 2299–2299. 146 indexed citations

Li, Nan, Lin Feng, Hui Liu, et al.. (2016). PARP Inhibition Suppresses Growth of EGFR-Mutant Cancers by Targeting Nuclear PKM2. Cell Reports. 15(4). 843–856. 47 indexed citations

Bharadwaj, Uddalak, T. Kris Eckols, Xuejun Xu, et al.. (2016). Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinoma. Oncotarget. 7(18). 26307–26330. 87 indexed citations

10.

Bocchini, Claire, Karen Nahmod, Panagiotis Katsonis, et al.. (2016). Protein stabilization improves STAT3 function in autosomal dominant hyper-IgE syndrome. Blood. 128(26). 3061–3072. 25 indexed citations

11.

Roh, Soung‐Hun, Moses M. Kasembeli, Jesús G. Galaz-Montoya, Wah Chiu, & David J. Tweardy. (2016). Chaperonin TRiC/CCT Recognizes Fusion Oncoprotein AML1-ETO through Subunit-Specific Interactions. Biophysical Journal. 110(11). 2377–2385. 11 indexed citations

12.

Robinson, Prema, et al.. (2016). Substance P Receptor Signaling Mediates Doxorubicin-Induced Cardiomyocyte Apoptosis and Triple-Negative Breast Cancer Chemoresistance. BioMed Research International. 2016. 1–9. 50 indexed citations

13.

Liu, Wei, Farrukh Vohidov, Moses M. Kasembeli, et al.. (2015). Rhodium(II) Proximity‐Labeling Identifies a Novel Target Site on STAT3 for Inhibitors with Potent Anti‐Leukemia Activity. Angewandte Chemie International Edition. 54(44). 13085–13089. 31 indexed citations

14.

Lewis, Katherine, Uddalak Bharadwaj, T. Kris Eckols, et al.. (2015). Small-molecule targeting of signal transducer and activator of transcription (STAT) 3 to treat non-small cell lung cancer. Lung Cancer. 90(2). 182–190. 46 indexed citations

15.

Roh, Soung‐Hun, Moses M. Kasembeli, Deenadayalan Bakthavatsalam, Wah Chiu, & David J. Tweardy. (2015). Contribution of the Type II Chaperonin, TRiC/CCT, to Oncogenesis. International Journal of Molecular Sciences. 16(11). 26706–26720. 64 indexed citations

16.

Roh, Soung‐Hun, Moses M. Kasembeli, Jesús G. Galaz-Montoya, et al.. (2015). Chaperonin TRiC/CCT Modulates the Folding and Activity of Leukemogenic Fusion Oncoprotein AML1-ETO. Journal of Biological Chemistry. 291(9). 4732–4741. 26 indexed citations

17.

Bharadwaj, Uddalak, T. Kris Eckols, Mikhail Kolosov, et al.. (2014). Drug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancer. Oncogene. 34(11). 1341–1353. 137 indexed citations

18.

Bocchini, Claire, Moses M. Kasembeli, Soung‐Hun Roh, & David J. Tweardy. (2014). Contribution of chaperones to STAT pathway signaling. PubMed. 3(3). e970459–e970459. 24 indexed citations

19.

Kasembeli, Moses M., Wilson Chun Yu Lau, Soung‐Hun Roh, et al.. (2014). Modulation of STAT3 Folding and Function by TRiC/CCT Chaperonin. PLoS Biology. 12(4). e1001844–e1001844. 80 indexed citations

20.

Xu, Xuejun, et al.. (2009). Chemical Probes that Competitively and Selectively Inhibit Stat3 Activation. PLoS ONE. 4(3). e4783–e4783. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact